当前位置: 首页 > 详情页

Urinary Alzheimer-Associated Neuronal Thread Protein is not Elevated in Patients with Subjective Cognitive Decline and Patients with Depressive State.

文献详情

资源类型:
WOS体系:

收录情况: ◇ SCIE

机构: [a]Central Laboratory, Xuanwu Hospital, Capital Medical University, Beijing, China [b]Department of Neurology, Xuanwu Hospital of Capital Medical University, Beijing, China [c]Beijing Geriatric Medical Research Center, Beijing, China [d]Center of Alzheimer’s Disease, Beijing Institute for Brain Disorders, Beijing, China [e]National Clinical Research Center for Geriatric Disorders, Beijing, China
出处:
ISSN:

关键词: Alzheimer-associated neuronal thread protein Alzheimer's disease biomarker depressive state subjective cognitive decline

摘要:
Subjective cognitive decline (SCD) is a risk factor for Alzheimer's disease (AD). Urinary Alzheimer-associated neuronal thread protein (AD7c-NTP) has been identified as a biomarker for AD. It was hypothesized that if urinary AD7c-NTP were also elevated in SCD, as it is in prodromal AD (mild cognitive impairment stage), it could be a convenient and efficient clinical biomarker for the early diagnosis of SCD. SCD is often accompanied by a depressive state (DS), and the impact of DS on urinary AD7c-NTP levels remains unknown. A total of 297 right-handed Chinese Han subjects were recruited, including 98 subjects with SCD, 92 patients with DS, and 107 well-matched cognitively normal controls (NC). The levels of AD7c-NTP in urine samples were measured using an enzyme-linked immunosorbent assay AD7c-NTP kit. Our results demonstrated that urinary AD7c-NTP levels in the SCD group (0.7561±0.5657 ng/mL) were not significantly higher than in either the DS (0.7527±0.5607 ng/mL) or NC (0.7214±0.5077 ng/mL) groups. Furthermore, urinary AD7c-NTP levels were not correlated with Hamilton Depression Rating Scale and Hamilton Anxiety Scale scores, but they were negatively associated with Mini-Mental State Examination scores (r = -0.222, p = 0.033) and Montreal Cognitive Assessment-Basic scores (r = -0.207, p = 0.048). Urinary AD7c-NTP level is not elevated in SCD and is unaffected by DS. Urinary AD7c-NTP may therefore not be a good potential biomarker for SCD and DS, although it may become elevated with more severe cognitive decline.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2018]版:
大类 | 2 区 医学
小类 | 3 区 神经科学
最新[2023]版:
大类 | 3 区 医学
小类 | 3 区 神经科学
JCR分区:
出版当年[2017]版:
Q2 NEUROSCIENCES
最新[2023]版:
Q2 NEUROSCIENCES

影响因子: 最新[2023版] 最新五年平均 出版当年[2017版] 出版当年五年平均 出版前一年[2016版] 出版后一年[2018版]

第一作者:
第一作者机构: [a]Central Laboratory, Xuanwu Hospital, Capital Medical University, Beijing, China [b]Department of Neurology, Xuanwu Hospital of Capital Medical University, Beijing, China
通讯作者:
通讯机构: [a]Central Laboratory, Xuanwu Hospital, Capital Medical University, Beijing, China [b]Department of Neurology, Xuanwu Hospital of Capital Medical University, Beijing, China [c]Beijing Geriatric Medical Research Center, Beijing, China [d]Center of Alzheimer’s Disease, Beijing Institute for Brain Disorders, Beijing, China [e]National Clinical Research Center for Geriatric Disorders, Beijing, China [*1]No.45, Changchun Street, Beijing 100053, P.R. China.
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:16461 今日访问量:0 总访问量:871 更新日期:2025-01-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学宣武医院 技术支持:重庆聚合科技有限公司 地址:北京市西城区长椿街45号宣武医院